BioAge Labs (BIOA) Financials

Balance sheets

Sep 30, 2024Jun 1, 2024Mar 1, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023

Total Assets

$337.4 M(+105.2%)$164.4 M(-8.5%)$179.6 M(+592.8%)$25.9 M---

Current Assets

$336.5 M(+105.6%)$163.7 M(-8.5%)$178.8 M(+606.6%)$25.3 M---

Non Current Assets

$914.0 K(+21.9%)$750.0 K(-5.8%)$796.0 K(+28.8%)$618.0 K---

Total Liabilities

$23.6 M(-93.5%)$361.5 M(-1.0%)$365.1 M(+83.2%)$199.3 M---

Current Liabilities

$19.1 M(+47.0%)$13.0 M(-14.3%)$15.1 M(-74.0%)$58.2 M---

Long Term Liabilities

$4.6 M(-98.7%)$348.6 M(-0.4%)$350.0 M(+147.9%)$141.2 M---

Shareholders Equity

$313.7 M(+259.2%)-$197.1 M(-6.3%)-$185.5 M(-7.0%)-$173.4 M---

Book Value

$313.7 M(+259.2%)-$197.1 M(-6.3%)-$185.5 M(-7.0%)-$173.4 M---

Working Capital

$317.4 M(+110.7%)$150.7 M(-7.9%)$163.7 M(+598.0%)-$32.9 M---

Cash And Cash Equivalents

$334.5 M(+110.3%)$159.1 M(-8.6%)$174.0 M(+703.9%)$21.6 M---

Accounts Payable

$2.1 M(+43.2%)$1.5 M(-36.8%)$2.3 M(+24.2%)$1.9 M---

Accounts Receivable

-------

Short Term Debt

$6.0 M(-4.7%)$6.3 M(+0.0%)$6.3 M(-86.0%)$44.9 M---

Long Term Debt

$3.9 M(-27.2%)$5.4 M(-21.6%)$6.9 M(-15.8%)$8.2 M---

Total Debt

$10.2 M(-12.8%)$11.7 M(-11.3%)$13.2 M(-75.2%)$53.3 M-$0.0(0%)$0.0

Debt To Equity

0.0(+150.0%)-0.1(+14.3%)-0.1(+77.4%)-0.3---

Current Ratio

17.6(+39.8%)12.6(+6.8%)11.8(+2584.1%)0.4---

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$231.7 M(-11.2%)-$208.3 M(-7.0%)-$194.7 M(-7.2%)-$181.7 M---

PB Ratio

2.0------

Income statements

Sep 30, 2024Jun 1, 2024Mar 1, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023

EPS

-$6.7(-1425.2%)-$0.4(-4.5%)-$0.4--$0.7(-30.7%)-$0.6(-55.0%)-$0.4

TTM EPS

-$7.6(-376.5%)-$1.6(+6.8%)-$1.7--$1.6(-79.5%)-$0.9(-155.1%)-$0.4

Revenue

$0.0--$0.0(0%)$0.0--

TTM Revenue

$0.0--$0.0(0%)$0.0--

Total Expenses

$24.8 M(+62.1%)$15.3 M(+19.2%)$12.8 M(-5.8%)$13.6 M(+37.5%)$9.9 M(-26.3%)$13.4 M(+16.6%)$11.5 M

Operating Expenses

$24.8 M(+62.1%)$15.3 M(+19.2%)$12.8 M(-5.8%)$13.6 M(+37.5%)$9.9 M(-26.3%)$13.4 M(+16.6%)$11.5 M

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

-$24.8 M(-62.1%)-$15.3 M(-19.2%)-$12.8 M(+5.8%)-$13.6 M(-37.5%)-$9.9 M(+26.3%)-$13.4 M(-16.6%)-$11.5 M

TTM Operating Profit

-$66.4 M(-28.8%)-$51.6 M(-3.7%)-$49.7 M(-2.7%)-$48.4 M(-39.1%)-$34.8 M(-39.7%)-$24.9 M(-116.6%)-$11.5 M

Operating Margin

-------

Net Income

-$23.4 M(-72.3%)-$13.6 M(-4.5%)-$13.0 M(+38.0%)-$21.0 M(-43.3%)-$14.6 M(+14.9%)-$17.2 M(-55.1%)-$11.1 M

TTM Net Income

-$70.9 M(-14.1%)-$62.2 M(+5.5%)-$65.8 M(-3.0%)-$63.9 M(-48.9%)-$42.9 M(-51.7%)-$28.3 M(-155.1%)-$11.1 M

Net Margin

-------

EBIT

-$23.0 M(-75.2%)-$13.1 M(-11.6%)-$11.8 M(+36.0%)-$18.4 M(-50.5%)-$12.2 M(+19.3%)-$15.1 M(-47.2%)-$10.3 M

TTM EBIT

-$66.3 M(-19.4%)-$55.5 M(+3.5%)-$57.5 M(-2.6%)-$56.1 M(-48.9%)-$37.7 M(-48.0%)-$25.4 M(-147.2%)-$10.3 M

EBITDA

-$22.7 M(-73.2%)-$13.1 M(-11.5%)-$11.7 M(+10.9%)-$13.2 M(-41.1%)-$9.3 M(+38.2%)-$15.1 M(-47.3%)-$10.3 M

TTM EBITDA

-$60.7 M(-28.2%)-$47.3 M(+4.1%)-$49.4 M(-3.1%)-$47.9 M(-38.0%)-$34.7 M(-36.8%)-$25.4 M(-147.3%)-$10.3 M

Selling, General & Administrative Expenses

$4.7 M(-1.4%)$4.8 M(+37.4%)$3.5 M(-0.6%)$3.5 M(+4.7%)$3.4 M(-19.7%)$4.2 M(+20.5%)$3.5 M

TTM SGA

$16.5 M(+9.1%)$15.2 M(+4.3%)$14.5 M(+0.2%)$14.5 M(+31.9%)$11.0 M(+43.9%)$7.6 M(+120.5%)$3.5 M

Depreciation And Amortization

$38.0 K(-22.4%)$49.0 K(+48.5%)$33.0 K(-19.5%)$41.0 K(-14.6%)$48.0 K(+20.0%)$40.0 K(+21.2%)$33.0 K

TTM D&A

$161.0 K(-5.8%)$171.0 K(+5.6%)$162.0 K(0%)$162.0 K(+33.9%)$121.0 K(+65.8%)$73.0 K(+121.2%)$33.0 K

Interest Expense

$388.0 K(-12.4%)$443.0 K(-63.6%)$1.2 M(-52.4%)$2.6 M(+6.5%)$2.4 M(+17.9%)$2.0 M(+157.1%)$793.0 K

TTM Interest Expense

$4.6 M(-30.4%)$6.6 M(-19.4%)$8.2 M(+5.4%)$7.8 M(+48.9%)$5.2 M(+84.8%)$2.8 M(+257.1%)$793.0 K

Income Tax

-------

TTM Income Tax

-------

PE Ratio

-------

PS Ratio

-------

Cashflow statements

Sep 30, 2024Jun 1, 2024Mar 1, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023

Cash From Operations

-$14.9 M(+5.4%)-$15.8 M(-0.7%)-$15.7 M(-84.3%)-$8.5 M(-9.5%)-$7.8 M(+30.0%)-$11.1 M(-10.9%)-$10.0 M

TTM CFO

-$54.9 M(-15.0%)-$47.7 M(-10.9%)-$43.0 M(-15.2%)-$37.4 M(-29.5%)-$28.9 M(-36.8%)-$21.1 M(-110.9%)-$10.0 M

Cash From Investing

-$305.0 K(-771.4%)-$35.0 K(-100.0%)$0.0(0%)$0.0(+100.0%)-$99.0 K(-76.8%)-$56.0 K(+49.5%)-$111.0 K

TTM CFI

-$340.0 K(-153.7%)-$134.0 K(+13.6%)-$155.0 K(+41.7%)-$266.0 K(0%)-$266.0 K(-59.3%)-$167.0 K(-50.5%)-$111.0 K

Cash From Financing

$190.7 M(+8088.4%)-$2.4 M(-101.4%)$168.0 M(+16750.3%)-$1.0 M(-2302.4%)-$42.0 K(-100.3%)$12.5 M(-46.8%)$23.5 M

TTM CFF

$355.3 M(+115.9%)$164.6 M(-8.3%)$179.4 M(+413.6%)$34.9 M(-2.8%)$36.0 M(-0.1%)$36.0 M(+53.2%)$23.5 M

Free Cash Flow

-$15.2 M(+3.7%)-$15.8 M(-0.9%)-$15.7 M(-84.3%)-$8.5 M(-8.2%)-$7.9 M(+29.5%)-$11.2 M(-11.4%)-$10.0 M

TTM FCF

-$55.2 M(-15.4%)-$47.9 M(-10.8%)-$43.2 M(-15.1%)-$37.5 M(-29.3%)-$29.0 M(-37.1%)-$21.2 M(-111.4%)-$10.0 M

CAPEX

$305.0 K---$99.0 K--

TTM CAPEX

$305.0 K---$99.0 K--

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------